We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Ganglioside Probes Enable Tracking of Membrane Lipid Rafts in Living Cells

By LabMedica International staff writers
Posted on 26 Apr 2016
A team of Japanese cell biologists developed a series of fluorescently labeled gangliosides that enabled them to visualize cell membrane lipid raft domains in living cells.

Combinations of glycosphingolipids and protein receptors are organized in glycolipoprotein microdomains known as lipid rafts within the cellular plasma membrane. More...
These specialized membrane microdomains compartmentalize cellular processes by serving as organizing centers for the assembly of signaling molecules, influencing membrane fluidity and membrane protein trafficking, and regulating neurotransmission and receptor trafficking. Lipid rafts are more highly ordered and tightly packed than the surrounding bilayer, but float freely in the membrane bilayer. Although more common in the plasma membrane, lipid rafts have also been reported in other parts of the cell, such as the Golgi apparatus and lysosomes.

The exact functions of lipid rafts are poorly understood, primarily because of the scarcity of suitable fluorescent ganglioside analogs to serve as tracer molecules. To correct this deficit, investigators at Kyoto University (Japan) synthesized four complete ganglioside molecules with fluorescent markers attached at specific locations. They used these tracers in a single-fluorescent-molecule living-cell imaging system.

Results published in the April 4, 2016, online edition of the journal Nature Chemical Biology revealed that in the live-cell plasma membrane there could be seen clear but transient co-localization and co-diffusion of fluorescent ganglioside analogs with a fluorescently labeled glycosylphosphatidylinisotol (GPI)-anchored protein, human CD59. The ganglioside molecules were always mobile in quiescent cells with extremely short interactions taking place that last for about 12 milliseconds for CD59 monomers, 40 milliseconds for CD59's transient homodimer rafts, and 48 milliseconds for engaged-CD59-cluster rafts, in cholesterol- and GPI-anchoring-dependent manners.

"Such dynamic behaviors were difficult to find using normal techniques, and our findings were made possible by single-molecule tracking of new fluorescent ganglioside probes," said contributing author Dr. Kenichi Suzuki, professor of membrane biology at Kyoto University. "Our findings established the concept of dynamic raft domains: their constituent molecules assemble to form raft domains, do their jobs within several tens of milliseconds, and then move away for the next assembly to perform the next task."

Related Links:
Kyoto University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.